Cost-utility analysis of risk-reducing strategies to prevent breast and ovarian cancer in BRCA-mutation carriers in Switzerland
Year of publication: |
2022
|
---|---|
Authors: | Bommer, Claudine ; Lupatsch, Judith ; Bürki, Nicole ; Schwenkglenks, Matthias |
Published in: |
The European journal of health economics. - Berlin : Springer, ISSN 1618-7601, ZDB-ID 2011428-X. - Vol. 23.2022, 5, p. 807-821
|
Subject: | BRCA | Breast cancer | Cost-effectiveness | Health economic modelling | Ovarian cancer | Risk reduction | Krebskrankheit | Cancer | Schweiz | Switzerland | Gesundheitsökonomik | Health economics | Gesundheitsvorsorge | Preventive care |
-
Müller, Dirk, (2018)
-
Health state utility values by cancer stage : a systematic literature review
Pourrahmat, Mir-Masoud, (2021)
-
The relative value of suicide prevention in health care priority setting
Andrén, Daniela, (2023)
- More ...
-
The lower educational success of boys
Hadjar, Andreas, (2010)
-
Barbier, Michaela, (2022)
-
Wieser, Simon, (2018)
- More ...